Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Quince Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +5 vs. Q1 2025
- Shares held
- 7.58M
- +2.35M (+44.9%) vs. Q1 2025
- Total value
- $12.5M
- +$5.55M (+79.8%) vs. Q1 2025
- New holders
- 10
- 7 more added
- Sold out
- 5
- 9 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 8 | $13 | 0.00% | +8 | New |
| Barclays PLC | 23 | $38 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $124 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 77 | $127 | 0.00% | +3+4.1% | Added |
| Harbour Investments, Inc. | 100 | $165 | 0.00% | +100 | New |
| Hurley Capital, LLC | 121 | $200 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 277 | $457 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 295 | $487 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $561 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 469 | $774 | 0.00% | −78−14.3% | Reduced |
| UBS Group AG | 2,846 | $4.70K | 0.00% | +2,140+303.1% | Added |
| Bank of America Corp | 2,904 | $4.79K | 0.00% | +60+2.1% | Added |
| Morgan Stanley | 4,302 | $7.10K | 0.00% | −49,272−92.0% | Reduced |
| Wells Fargo & Company | 6,990 | $11.5K | 0.00% | +6,990 | New |
| Nixon Peabody Trust Co | 11,126 | $18.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,004 | $19.8K | 0.00% | +12,004 | New |
| Cambridge Investment Research Advisors, Inc. | 15,200 | $25.0K | 0.00% | +15,200 | New |
| Two Sigma Investments, LP | 17,386 | $28.7K | 0.00% | −23,764−57.7% | Reduced |
| XTX Topco Ltd | 22,660 | $37.4K | 0.00% | +22,660 | New |
| Anfield Capital Management, LLC | 30,227 | $49.9K | 0.02% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 33,818 | $56.0K | 0.00% | −2,809−7.7% | Reduced |
| Intellectus Partners, LLC | 53,312 | $88.0K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 77,492 | $127.9K | 0.00% | 00.0% | Unchanged |
| Scharf Investments, LLC | 91,061 | $150.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 93,905 | $154.9K | 0.00% | +53,508+132.5% | Added |
| Millennium Management LLC | 110,682 | $182.6K | 0.00% | +110,682 | New |
| Union Square Park Capital Management, LLC | 120,857 | $199.4K | 0.17% | +120,857 | New |
| Mariner, LLC | 122,461 | $202.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 124,911 | $206.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 128,617 | $212.2K | 0.01% | +22,200+20.9% | Added |
| ADAR1 Capital Management, LLC | 142,958 | $235.9K | 0.04% | 00.0% | Unchanged |
| Shay Capital LLC | 150,000 | $247.5K | 0.06% | −34,334−18.6% | Reduced |
| Rockefeller Capital Management L.P. | 169,554 | $279.8K | 0.00% | +169,554 | New |
| Alphabet Inc. | 189,122 | $312.1K | 0.01% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 308,500 | $509.0K | 0.00% | −35,070−10.2% | Reduced |
| BlackRock, Inc. | 335,738 | $554.0K | 0.00% | −9,710−2.8% | Reduced |
| Renaissance Technologies LLC | 379,800 | $626.7K | 0.00% | −120,107−24.0% | Reduced |
| Geode Capital Management, LLC | 396,982 | $655.1K | 0.00% | +1,272+0.3% | Added |
| Ieq Capital, LLC | 439,270 | $724.8K | 0.00% | −367,510−45.6% | Reduced |
| Vanguard Group Inc | 1,454,038 | $2.40M | 0.00% | +168,265+13.1% | Added |
| Nantahala Capital Management, LLC | 2,528,302 | $4.17M | 0.30% | +2,528,302 | New |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −184,383−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −43,332−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −14,613−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −246−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |